How Mark Cuban’s Drug Prices Compare to Corporate-Owned Pharmacies
Ken Alltucker and USA TODAY on October 8, 2026
A separate study found insured shoppers with copays of at least $15 could save by paying cash at direct-to-consumer pharmacies nearly 80% of the time.
The Typical New Drug Costs $250K per Year. Why Prices March Higher
Ken Alltucker and USA TODAY on October 3, 2026
A JAMA analysis found prices climbed from $39,000 in 2008, even as experts caution list prices aren’t what insured patients usually pay
Lilly’s Retatrutide GLP-1 Delivers Average Weight Loss of 50 Pounds
Ken Alltucker and USA TODAY on September 30, 2026
The experimental drug is not FDA-approved, and its biologic classification could shape when lower-cost competitors reach patients if regulators approve it.
Medicare Unveils 2027 Rates for Private Medicare, Part D Plans
Ken Alltucker and USA TODAY on September 28, 2026
The average Part D premium is projected to rise by less than $1; drug lists and provider networks may still shift before enrollment.
Vance, Oz Probe Cuts Off Subsidies to Thousands of Obamacare Enrollees
Ken Alltucker and USA TODAY on September 22, 2026
The move could affect coverage costs for people whose income, employer benefits or enrollment records no longer qualify for federal help.
New Survey Shows How Many Insured Americans Still Owe Money on Medical Bills
Ken Alltucker and USA TODAY on September 17, 2026
Nearly half of insured adults carrying medical debt owe at least $2,000, while many lack enough savings to cover a $1,000 surprise bill.
‘Microdosing’ GLP-1s Can Shed Pounds, but Here Are the Dangers
Ken Alltucker and USA TODAY on September 3, 2026
A study of more than 1,000 patients found modest weight loss and raised questions about side effects at starter doses.
Trump Touts Drug-Pricing Pacts With These 9 Pharma Manufacturers
Ken Alltucker and USA TODAY on August 31, 2026
The agreements target Medicaid prices, but unpublished terms and insurance rules leave consumers with important questions about potential savings.
Eli Lilly’s Diabetes Drug Mounjaro Gets Approval for a New Use
Ken Alltucker and USA TODAY on August 28, 2026
The new indication could affect coverage decisions for high-risk adults, while insurers already distinguish diabetes treatment from weight-loss prescriptions.
A Federal Fix Awards Doctors Billions. It Could Mean Pricier Insurance
Ken Alltucker and USA TODAY on August 26, 2026
The arbitration system stopped many surprise bills, but provider payouts soared to $16.6 billion in 2025, potentially shifting costs to policyholders
Wegovy and Zepbound Are Changing How Americans Get Health Care
Ken Alltucker and USA TODAY on August 20, 2026
Bariatric surgeries fell 34% as GLP-1 use surged 140%, while insurers and employers reconsider who should pay for these costly drugs.
Gen Z Seeks to Optimize Sleep and Is Willing to Pay for ‘SleepMaxxing’
Ken Alltucker and USA TODAY on August 17, 2026
An HSA may cover some sleep products, but experts warn that viral hacks such as mouth taping lack strong evidence and can create health risks.
Americans Want Lower Health Care Costs. This Is How They’d Get It
Ken Alltucker and USA TODAY on August 13, 2026
A survey of more than 25,000 adults shows why premiums, deductibles and Medicaid coverage are straining household budgets across party lines.
Two Pain Drugs Used by Millions Will Be Combined in a Single Tablet
Ken Alltucker and USA TODAY on July 24, 2026
An FDA-approved combo of Tylenol and naproxen promises up to 12 hours of relief — here’s when it hits store shelves.
Generic Drug Tariffs Set to Skyrocket in 2028. Consumers Could Feel Impact
Ken Alltucker and USA TODAY on July 22, 2026
A 100% tariff hits in 2028, then 200% a year later — squeezing the generics that fill 90% of U.S. prescriptions.
Taco Bell Locations Remove Ingredients Amid Cyclosporiasis Outbreak
Ken Alltucker and USA TODAY on July 15, 2026
More than 1,600 confirmed cases across 34 states have officials scrambling to trace the source, and Taco Bell isn’t ruled out.
CDC Says 4 States Likely Linked in Cyclosporiasis Outbreak. See Which Ones
Ken Alltucker and USA TODAY on July 14, 2026
Officials suspect lettuce as confirmed cases top 1,600 across 34 states, with Michigan, Ohio, West Virginia and Kentucky forming a likely-linked cluster.
The US Spends Billions on These Senior Homes in ‘Huge Oversight Gap’
Ken Alltucker and USA TODAY on July 2, 2026
A federal watchdog found Medicare and Medicaid funneled $12 billion to assisted-living facilities in 2024 with almost no oversight of care quality.
Millions Drop ACA Coverage Amid Price Jump. Did Fraud Inflate Signups?
Ken Alltucker and USA TODAY on June 30, 2026
HHS blames fraud crackdowns for the exodus, but experts say a 114% premium spike is the real reason coverage lapsed.
Medicare Will Help Pay for Weight-Loss Drugs Wegovy, Zepbound. What to Know
Ken Alltucker and USA TODAY on June 29, 2026
Starting July 1, qualifying Medicare enrollees can get Wegovy or Zepbound for just $50 a month — but the eligibility rules are stricter than you might expect.
1 - 20 of 38